Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

708
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
708
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

666
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
666
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

2.1K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.1K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

739
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
739
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

962
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
962
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

555
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
555

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroimaging in schizophrenia: From group-average abnormalities to individualised circuit models.

Science progress·2026
Same author

Sleep, mood, and binge eating: Evidence from a student sample.

Eating behaviors·2026
Same author

Food-Related Attentional Biases in Restrained Eaters: A Meta-Analysis.

The International journal of eating disorders·2026
Same author

Why we value things more as we are about to lose them: A reference-based theory.

Neuroscience and biobehavioral reviews·2026
Same author

On the origin of the reward function: Exploring the role of conditioned reinforcement and social learning.

Psychonomic bulletin & review·2025
Same author

Integrated care in practice: lessons from three tiers of healthcare provider and commissioner staff in two London Integrated Care Systems.

BJPsych open·2025
Same journal

Effect of Australian telepsychiatry services on attention-deficit hyperactivity disorder prescriptions.

Psychiatry research·2026
Same journal

Cognitive correlates of Antisaccade Task performance in bipolar disorder.

Psychiatry research·2026
Same journal

National estimates of exposure to potentially traumatic events among individuals with obsessive-compulsive disorder: Findings from The National OCD Survey.

Psychiatry research·2026
Same journal

Digitally delivered cognitive bias modification for interpretation targeting hostile interpretation bias in compulsory drug rehabilitation: A feasibility randomized trial.

Psychiatry research·2026
Same journal

Association of TyG-RFM with depressive symptoms: a nationally representative study enhanced by interpretable machine learning.

Psychiatry research·2026
Same journal

Cross-national patterns of probable complex PTSD in post-communist Europe: A network analysis of five countries.

Psychiatry research·2026
See all related articles

Related Experiment Video

Updated: Feb 19, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.7K

Decreased value-sensitivity in schizophrenia.

Cristina Martinelli1, Francesco Rigoli2, Ray J Dolan3

  • 1Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, SE5 8AF London, United Kingdom.

Psychiatry Research
|November 3, 2017
PubMed
Summary
This summary is machine-generated.

Schizophrenia patients show reduced sensitivity to monetary value in risky choices. This impaired value processing is linked to aberrant salience, suggesting a target for cognitive interventions.

More Related Videos

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.4K
Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
09:29

Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder

Published on: January 9, 2015

15.9K

Related Experiment Videos

Last Updated: Feb 19, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.7K
Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.4K
Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
09:29

Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder

Published on: January 9, 2015

15.9K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Cognitive Science

Background:

  • Schizophrenia pathophysiology involves aberrant incentive salience and dysfunctional value processing.
  • Dopaminergic abnormalities are implicated in impaired value learning in schizophrenia.
  • Value-guided decision-making, particularly under risk, is underexplored in schizophrenia.

Purpose of the Study:

  • To investigate value-guided choice under risk in schizophrenia patients.
  • To examine how patients with schizophrenia use value to guide behavior independently of learning.
  • To explore the relationship between value sensitivity and aberrant salience in schizophrenia.

Main Methods:

  • A risky choice task comparing monetary rewards and gambles was administered to schizophrenia patients and controls.
  • Choices between a certain reward and a probabilistic gamble were analyzed.
  • Sensitivity to varying monetary values and its correlation with aberrant salience were assessed.

Main Results:

  • Schizophrenia patients exhibited significantly reduced sensitivity to monetary values compared to controls.
  • Patient choices did not flexibly adapt to the specific values presented.
  • Lower value sensitivity inversely correlated with aberrant salience experience.

Conclusions:

  • Reduced value sensitivity is a key cognitive deficit in schizophrenia, impacting decision-making under risk.
  • The inability to tune choice to value may be a critical component of aberrant salience in schizophrenia.
  • Findings suggest potential targets for cognitive interventions to improve value sensitivity in schizophrenia.